TRV GP IV’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Hold |
2,132,867
| – | – | 1.51% | 3 |
|
|
2025
Q1 | $2.88M | Hold |
2,132,867
| – | – | 3.1% | 3 |
|
|
2024
Q4 | $28.1M | Hold |
2,132,867
| – | – | 35.03% | 2 |
|
|
2024
Q3 | $23.9M | Hold |
2,132,867
| – | – | 14.75% | 2 |
|
|
2024
Q2 | $22.9M | Hold |
2,132,867
| – | – | 11.34% | 2 |
|
|
2024
Q1 | $31.8M | Hold |
2,132,867
| – | – | 15.4% | 2 |
|
|
2023
Q4 | $38.6M | Hold |
2,132,867
| – | – | 15.69% | 2 |
|
|
2023
Q3 | $37M | Hold |
2,132,867
| – | – | 13.93% | 2 |
|
|
2023
Q2 | $38.6M | Hold |
2,132,867
| – | – | 34.92% | 2 |
|
|
2023
Q1 | $56.7M | Hold |
2,132,867
| – | – | 40.55% | 2 |
|
|
2022
Q4 | $41.2M | Hold |
2,132,867
| – | – | 17.53% | 2 |
|
|
2022
Q3 | $44.6M | Hold |
2,132,867
| – | – | 26.04% | 2 |
|
|
2022
Q2 | $17.1M | Hold |
2,132,867
| – | – | 11.23% | 3 |
|
|
2022
Q1 | $15M | Hold |
2,132,867
| – | – | 5.48% | 5 |
|
|
2021
Q4 | $28.8M | Hold |
2,132,867
| – | – | 8.28% | 5 |
|
|
2021
Q3 | $36M | Hold |
2,132,867
| – | – | 8.17% | 5 |
|
|
2021
Q2 | $62.1M | Hold |
2,132,867
| – | – | 29.57% | 2 |
|
|
2021
Q1 | $83.9M | Hold |
2,132,867
| – | – | 30.9% | 2 |
|
|
2020
Q4 | $48.5M | Hold |
2,132,867
| – | – | 15.55% | 4 |
|
|
2020
Q3 | $48.3M | Hold |
2,132,867
| – | – | 16.63% | 4 |
|
|
2020
Q2 | $69.2M | Buy |
+2,132,867
| New | +$69.2M | 31.9% | 1 |
|